Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"
"Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment" ADAPT Biobank
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1,000 participants
Dec 18, 2014
OBSERVATIONAL
Conditions
Summary
The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis. Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Eligibility
Inclusion Criteria27
- Patients visiting the AMC outpatient clinic
- Patients included in an ongoing clinical trial linked to this biobank. Studies are listed under point "Groups and interventions" and include:
- MARK AF
- INDICO AF
- PREDICT AF
- WEIGHTLOSS AF
- MAD AF
- Patients included in future clinical trial linked to this biobank. Studies may be linked to this biobank that investigates prevalent or incident cardiac arrhythmias.
- Cardiac arrhtymias are defined as
- Supraventricular tachycardia, among which the most common are:
- Atrial Fibrillation (AF)
- Atrial Tachycardia (AT)
- Atrial Flutter (AFL)
- Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
- Atrioventricular Reentrant Tachycardia (AVRT)
- Ventricular tachycardia, among which the most common are:
- Ventricular Tachycardia (VT)
- Ventricular Flutter (VFL)
- Ventricular Fibrillation (VF)
- Bradycardia:
- Sinus Node Dysfunction
- AV Node Dysfunction
- Interventricular Conduction Disorder
- Arrhythmogenic cardiomyopathies, among which the most common are:
- Dilated Cardiomyopathy
- Restrictive Cardiomyopathy
- Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Exclusion Criteria4
- Age \< 18
- Unable or unwilling to comply with study procedures
- Pregnancy or of childbearing potential without adequate contraception
- NYHA class IV heart failure symptoms or left ventricular ejection fraction \<35%.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04776642